In vivo genome editing using Staphylococcus aureus Cas9
Ran et al. (2015). NatureResearch
SpCas9's size limited AAV packaging for in vivo editing, and alternatives like St1Cas9 had drawbacks. This paper found S. aureus Cas9 (SaCas9), over 1 kb shorter than SpCas9, matching its efficiency. AAV8-delivered SaCas9 targeting Pcsk9 cut serum Pcsk9 by 95% in mice.
Described parts & designs
Identifiers & revision
DOI 10.1038/nature14299OpenAlex W2070614858PubMed 25830891
